ArrowMark Colorado Holdings LLC 13D and 13G filings for Heron Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 5:42 pm Sale | 2022-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 3,560,848 3.000% | -2,845,017 (-44.41%) | Filing |
| 2022-02-14 2:15 pm Purchase | 2021-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 6,405,865 6.280% | 1,044,254 (+19.48%) | Filing |
| 2021-02-16 1:29 pm Purchase | 2020-12-31 | 13G | Heron Therapeutics, Inc. HRTX | ArrowMark Colorado Holdings LLC | 5,361,611 5.900% | 5,361,611 (New Position) | Filing |